Experience and vision
DxTerity's leadership has extensive experience in advancing cutting-edge technology that redefines healthcare.
What drives us
Patient-first
At-home collection, simple workflows, and actionable results.
Scientific rigor
Peer-reviewed research and clinical validation at every step.
Access & equity
Removing geographic barriers to quality diagnostics.
Robert Terbrueggen, PhD
CEO and Founder
20+ years in genomics. Inventor of DxDirect Technology. Previously Director of R&D at Clinical Micro Sensors, Director of Research for Motorola Life Sciences. 26 issued US patents, 100+ international patents. PhD Chemistry from Caltech.
James Healy, MS
CFO and SVP Business Development
25 years of operations and financial leadership. Co-founded DxTerity Diagnostics with Bob. Cofounded JTA Research (acquired by Cadence). SVP for Cadence Design in Business Development. Previously CFO and SVP business development at Magnify360 a marketing automation firm. CFO and COO Hughes communication products. leading $250M+ in new business in high speed communication infrastructure.
Aviva Jacobs, PhD, PMP
VP, Product Development
20 years in IVD industry. Led FDA clearance of genetic tests for Warfarin, cystic fibrosis, and thrombophilia at GenMark Diagnostics. Oversaw BARDA-funded radiation exposure test development. PhD Genetics from George Washington University.
CAP Accreditation
CAP: 8680553, AU-ID: 1664134College of American Pathologists accreditation ensuring the highest standards of laboratory testing quality.
CLIA Certificate
05D2054007
Certificate of Accreditation under the Clinical Laboratory Improvement Amendments program.
ISO 13485:2016
ISO CertificateInternational standard for quality management systems in medical device manufacturing and design.
California State License
CDF-00343579State of California Department of Public Health clinical laboratory license.
FDA EUA Authorization
EUA202120 (Granted 8/28/2020)Emergency Use Authorization for the DxTerity SARS-CoV-2 RT-PCR CE Test.
Maryland State License
MD: Non-Expiring
Maryland Departmnet of Health Office of Healh Care Quality Clinical Laboratory Permit
Rhode Island State License
LCO01761State of Rhode Island Department of Health Center for Health Facilities Regulations.
2006
Founded
50+
US patents
12+
Publications
1M+
Tests processed
Compliance commitment
CAP-accredited, CLIA lab tests and IVD are run in accordance with applicable federal, state, and local regulations.
Contact Us
Stay in the know.
Get the latest updates and news.
DxTerity’s patient-focused mission is to bring the power of at-home RNA-based genomic monitoring to improve the management of immune-mediated diseases and overall patient well-being.
Experience and vision
DxTerity's leadership has extensive experience in advancing cutting-edge technology that redefines healthcare.
What drives us
Patient-first
At-home collection, simple workflows, and actionable results.
Scientific rigor
Peer-reviewed research and clinical validation at every step.
Access & equity
Removing geographic barriers to quality diagnostics.
Robert Terbrueggen, PhD
CEO and Founder
20+ years in genomics. Inventor of DxDirect Technology. Previously Director of R&D at Clinical Micro Sensors, Director of Research for Motorola Life Sciences. 26 issued US patents, 100+ international patents. PhD Chemistry from Caltech.
James Healy, MS
CFO and SVP Business Development
25 years of operations and financial leadership. Co-founded DxTerity Diagnostics with Bob. Cofounded JTA Research (acquired by Cadence). SVP for Cadence Design in Business Development. Previously CFO and SVP business development at Magnify360 a marketing automation firm. CFO and COO Hughes communication products. leading $250M+ in new business in high speed communication infrastructure.
Aviva Jacobs, PhD, PMP
VP, Product Development
20 years in IVD industry. Led FDA clearance of genetic tests for Warfarin, cystic fibrosis, and thrombophilia at GenMark Diagnostics. Oversaw BARDA-funded radiation exposure test development. PhD Genetics from George Washington University.
CAP Accreditation
CAP: 8680553, AU-ID: 1664134College of American Pathologists accreditation ensuring the highest standards of laboratory testing quality.
CLIA Certificate
05D2054007Certificate of Accreditation under the Clinical Laboratory Improvement Amendments program.
ISO 13485:2016
ISO CertificateInternational standard for quality management systems in medical device manufacturing and design.
California State License
CDF-00343579State of California Department of Public Health clinical laboratory license.
FDA EUA Authorization
EUA202120 (Granted 8/28/2020)Emergency Use Authorization for the DxTerity SARS-CoV-2 RT-PCR CE Test.
Maryland State License
MD: Non ExpiringMaryland Department of Health Office of Health Care Quality Clinical Laboratory Permit.
Rhode Island State License
License Number: LCO01761State of Rhode Island Department of Health Center for Health Facilities Regulations.
2006
Founded
50+
US patents
12+
Publications
1M+
Tests processed
Compliance commitment
CAP-accredited, CLIA lab tests and IVD are run in accordance with applicable federal, state, and local regulations.
Contact Us
Stay in the know.
Get the latest updates and news.
DxTerity’s patient-focused mission is to bring the power of at-home RNA-based genomic monitoring to improve the management of immune-mediated diseases and overall patient well-being.